Financial Ratios

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private
BSE1215.40-7.8 (-0.64 %)
PREV CLOSE ( ) 1223.20
OPEN PRICE ( ) 1213.90
BID PRICE (QTY) 1212.20 (1)
OFFER PRICE (QTY) 1215.30 (4)
VOLUME 685
TODAY'S LOW / HIGH ( )1202.05 1225.85
52 WK LOW / HIGH ( )1063.35 1888.05
NSE1214.25-11.6 (-0.95 %)
PREV CLOSE( ) 1225.85
OPEN PRICE ( ) 1212.00
BID PRICE (QTY) 1212.65 (1)
OFFER PRICE (QTY) 1214.40 (1)
VOLUME 7089
TODAY'S LOW / HIGH( ) 1204.15 1225.90
52 WK LOW / HIGH ( )1061.35 1887.95
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)18.2643.3125.5743.5125.12
   CEPS(Rs)22.5747.0028.9219.7912.05
   DPS(Rs)2.002.005.000.000.00
   Book NAV/Share(Rs)227.74211.5480.61142.4499.11
   Tax Rate(%)-4.217.0513.4620.9323.62
Margin Ratios
   Core EBITDA Margin(%)13.5624.7722.4620.7616.36
   EBIT Margin(%)11.7225.3421.9019.0914.96
   Pre Tax Margin(%)9.6124.1320.3817.4213.02
   PAT Margin (%)10.0122.4217.6413.779.95
   Cash Profit Margin (%)12.3824.3419.9515.6611.93
Performance Ratios
   ROA(%)5.7419.4418.1816.1612.10
   ROE(%)8.3130.4337.1636.0328.76
   ROCE(%)7.4925.7927.8826.7822.19
   Asset Turnover(x)0.570.871.031.171.22
   Sales/Fixed Asset(x)1.932.632.232.592.84
   Working Capital/Sales(x)6.051.654.736.174.95
Efficiency Ratios
   Fixed Capital/Sales(x)0.520.380.450.390.35
   Receivable days68.4964.7888.5768.7572.32
   Inventory Days140.9697.6679.6564.5449.92
   Payable days62.1284.6396.3074.7275.01
Valuation Parameters
   PER(x)91.3153.290.000.000.00
   PCE(x)73.8749.100.000.000.00
   Price/Book(x)7.3210.910.000.000.00
   Yield(%)0.120.09
   EV/Net Sales(x)9.4911.830.370.350.34
   EV/Core EBITDA(x)63.2543.391.511.672.07
   EV/EBIT(x)80.8046.661.671.832.29
   EV/CE(x)5.157.580.330.360.37
   M Cap / Sales9.1711.960.000.000.00
Growth Ratio
   Net Sales Growth(%)-5.7946.9214.7125.1056.77
   Core EBITDA Growth(%)-48.1365.4632.3658.3733.74
   EBIT Growth(%)-56.3470.0931.5559.6340.97
   PAT Growth(%)-57.8486.8946.9073.2069.46
   EPS Growth(%)-57.8469.38-41.2473.2069.46
Financial Stability Ratios
   Total Debt/Equity(x)0.340.260.560.790.97
   Current Ratio(x)1.272.341.481.471.57
   Quick Ratio(x)0.651.510.950.801.14
   Interest Cover(x)5.5620.9014.4511.407.71
   Total Debt/Mcap(x)0.050.02

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.